超声引导下逆行注射聚多卡醇静脉内微泡沫与静脉内激光消融治疗浅静脉功能不全的大样本患者队列
该单中心回顾性病历 review 纳入1070例CEAP C2-C6级、大隐静脉或前副大隐静脉反流的有症状患者,分别接受逆行超声引导下聚多卡醇静脉内微泡沫1%(PEM,550例)或静脉内激光消融(EVLA,520例)。PEM组和EVLA组消除反流率分别为93.5%(514/550)和92.8%(482/520),作者认为PEM在安全性和有效性上与EVLA相当,且PEM对多数C6患者有效,两组闭合率在治疗后36个月维持。
要点
- PEM组消除反流率93.5%(514/550),EVLA组92.8%(482/520),两组闭合率在治疗后36个月维持。
- C6患者中,PEM组69%溃疡(11/16)在不到1个月内愈合,EVLA组为5%(1/21)。
- PEM组无神经或心脏不良事件,EVLA组随访期间18%患者因患肢残留症状返回接受额外治疗。
核心结论
- 作者认为PEM在治疗大隐静脉反流及相关症状的安全性和有效性上与EVLA相当,且PEM对多数C6患者是有效干预,两组闭合率在治疗后36个月维持。
研究设计与样本
- 单中心静脉中心的回顾性病历 review,纳入2013年10月至2019年6月间1070例CEAP C2至C6级、大隐静脉或前副大隐静脉有症状浅静脉反流的患者。
- PEM组550例手术,随访43 ± 13个月;EVLA组520例手术,随访57 ± 18个月。
主要发现
- 完全治疗后消除反流的记录分别为PEM组93.5%(514/550)和EVLA组92.8%(482/520)。
- 随访期间,18%接受EVLA治疗的患者因患肢残留症状返回接受额外治疗。
- C6患者中,PEM组69%溃疡(11/16)在不到1个月内愈合,EVLA组为5%(1/21)。
- C4级有病变患者中,自发性出血消退率两组均为100%。
- PEM组无神经或心脏不良事件;PEM组轻微并发症包括无症状深静脉血栓(0.5%)、1例股总静脉血栓延伸和浅静脉血栓(4%);EVLA组包括无症状深静脉血栓(0.8%)和2例静脉内热诱导血栓形成。
临床怎么用
- 作者认为PEM在安全性和有效性上与EVLA相当,可用于治疗大隐静脉反流及相关症状;PEM对多数C6患者是有效干预;两组闭合率在治疗后36个月维持。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate outcomes among symptomatic patients with superficial chronic venous insufficiency treated with retrograde ultrasound-guided polidocanol endovenous microfoam 1% (PEM) or endovenous laser ablation (EVLA). METHODS: This study is a retrospective chart review from a single vein center between October 2013 and June 2019. Procedures were performed on 1070 patients with Clinical, Etiologic, Anatomic, and Pathophysiologic class 2 to 6 disease and symptomatic superficial venous reflux of the great saphenous vein or anterior accessory saphenous vein. RESULTS: PEM was used for 550 procedures and patients were followed for 43 ± 13 months; EVLA was used for 520 procedures and patients were followed for 57 ± 18 months. After complete treatment, the elimination of reflux was documented in 93.5% (514/550) and 92.8% (482/520) of the PEM and EVLA procedures, respectively. During the follow-up period, 18% of patients treated with EVLA returned for additional treatment to address residual symptoms in the affected leg. In C6 patients treated with PEM, 69% of ulcers (11/16) healed in less than 1 month, compared with 5% of patients (1/21) treated with EVLA. In C4 patients with lesions, resolution of spontaneous bleeding was 100% in both groups. There were no neurological or cardiac adverse events in the PEM group. Minor complications included asymptomatic deep vein thrombosis (0.5%), one common femoral vein thrombus extension, and superficial venous thrombosis (4%) in the PEM group and asymptomatic deep vein thrombosis (0.8%) and two endovenous heat-induced thromboses in the EVLA group. CONCLUSIONS: PEM is comparable in safety and efficacy with EVLA for the treatment of saphenous reflux and associated symptoms. PEM was an effective intervention for most patients with C6 disease. Closure rates in both groups were maintained 36 months after treatment.
引用
- Deak ST. Treatment of superficial venous insufficiency in a large patient cohort with retrograde administration of ultrasound-guided polidocanol endovenous microfoam versus endovenous laser ablation. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34958977. doi:10.1016/j.jvsv.2021.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。